Effect of Platelet-rich Factor on Implant Stability and Bone Resorption in the Lower Posterior Mandible
NCT ID: NCT02349620
Last Updated: 2015-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
30 participants
INTERVENTIONAL
2014-09-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of L-PRF on Implant Stability and Marginal Bone Levels.
NCT06516263
The Effect of Platelet Rich Fibrin Layers on Peri-implant Tissue Phenotype
NCT07033351
Influence of Human Platelet Derivatives on Dental Implant
NCT06044246
Impact of Biological Factors on Dental Implant
NCT06037070
Evaluation of Dental Implants Placed in Preserved and Non-preserved Post-extraction Ridges
NCT03715439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A:partialy edutolus patients
In this group surface treated implant with PRF will be inserted.Immediately after the surgery the implant stability will be measure with the Osstell mentor to verify the resonance frequency analysis (RFA), using the smart peg type 1, then stability will be measured every 2 weeks up to 3 months .Bone height will be measured in mesial and distal side immediately after placement and in months 3 and 6 with Intra Oral Peri Apical xray (IOPA x-ray)
PRF
implant stability was measured by RFA and implant resorption was measured by IOPA after surface treatment by PRF
B: partialy edutolus patients
In this group implant with out PRF will be inserted.Immediately after the surgery the implant stability will be measured with the Osstell mentor to verify the resonance frequence analysis (RFA ), using the smartpeg type 1, then stability will be measured every 2 weeks up to 3 months. Bone height was measured in mesial and distal side immediately after placement and in months 3 and 6 with IOPA xray
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRF
implant stability was measured by RFA and implant resorption was measured by IOPA after surface treatment by PRF
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adequate bone quantity and quality at the implant site
* the implant sites with at least 3 months of healing after extraction,
* patients well motivated for implant therapy and maintaining good oral hygiene
* the implant sites with width and length to installation of an implant of 4.5 mm x 11.5 mm.
* Patients who gave written informed consent
Exclusion Criteria
* infection around the implant site
* history of bruxism/parafunctional habits
* patients with history of any bleeding disorder or on anti-coagulant therapy.
* pregnant patients
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reza Tabrizi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reza Tabrizi
Assistant professor of shahid beheshti university of medical sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reza Tabrizi, DMD
Role: STUDY_CHAIR
Shiraz University of Medical Sciences
Touba karagah, DMD
Role: PRINCIPAL_INVESTIGATOR
Shiraz University of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shiraz university of medical sciences
Shiraz, Fars, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
123456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.